Catalyst Inc. (CBIO) - NASDAQ
Company Description
Catalyst Biosciences, Inc. Formerly known as Targacept, Inc.. The Company's principal activity is to design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the central nervous system by selectively targeting a class of receptors known as neuronal... More
Sector: Healthcare
Industry: Biotechnology
Country: United States